Reports Q2 revenue $11M, vs. $8.26M last year. “We are pleased with both our second quarter performance, which was in-line with the preliminary estimates, and the momentum in our business,” said Rob Ball, CEO of Shoulder Innovations (SI). “Our financial results and operational progress reflect accelerating market adoption of our advanced implant systems for anatomic and reverse total shoulder arthroplasty. Additionally, we are expanding our base of surgeon customers, which increased nearly 50% year-over-year in the second quarter.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SI:
- 2 New IPOs on the Street – Morgan Stanley Chooses the Superior Stock to Buy
- Figma initiated, Okta upgraded: Wall Street’s top analyst calls
- Shoulder Innovations initiated with an Overweight at Morgan Stanley
- Shoulder Innovations initiated with a Buy at Jefferies
- Shoulder Innovations initiated with an Overweight at Piper Sandler